29th May 2009 10:51
|
For Immediate Release |
29 May 2009 |
MINSTER PHARMACEUTICALS PLC (THE "COMPANY")
GRANT OF SHARE OPTION TO DIRECTOR
Minster Pharmaceuticals plc (AIM: MPM) announces that, on 28 May 2009, Dr Karl Keegan, recently appointed as Chief Financial Officer and an Executive Director of the Company, was granted an option over 250,000 ordinary shares of 5p each at an exercise price of 10p per ordinary share. This option is exercisable in full during the period commencing on the date of grant and terminating on 31 December 2014, subject to the continued tenure of Dr Keegan with the Company as an Executive Director.
Following the grant of the option referred to above, Dr Keegan is interested in 250,000 ordinary shares of 5p each in the ordinary share capital of the Company, representing 0.42% of the Company's issued ordinary share capital as at 28 May 2009.
For further information, please contact:
|
Minster Pharmaceuticals plc |
|
|
Jeremy Gorman, Company Secretary |
Tel: +44 (0) 20 7935 0027 |
|
Buchanan Communications |
Tel: +44 (0) 20 7466 5000 |
|
Mark Court / Rebecca Skye Dietrich / Catherine Breen |
|
|
Nomura Code Securities Limited |
Tel: +44 (0) 20 7776 1200 |
|
Richard Potts, Nominated Adviser & Stockbroker |
Related Shares:
MPM.L